Assessment of Right
Ventricular Function in Post Operative Patients of Tetralogy of Fallots and Its Predictive Factors
The drug, MYK - 461, was shown to normalize left
ventricular function in five cats with HCM.
Widya, R. L., Hammer, S., Boon, M. R., Van Der Meer, R. W., Smit, J. W. A. et al. «Effects of Short - Term Nutritional Interventions on Right
Ventricular Function in Healthy Men,» PloS One, 8 (9), E76406.
Investigators noted that the race induced a decrease in left and right
ventricular function in half of the amateur distance runners.
This resulted in increased basal myocardial adenylyl cyclase activity, enhanced atrial contractility, and increased left
ventricular function in vivo; these parameters at baseline in the transgenic animals were equal to those observed in control animals maximally stimulated with isoproterenol.
Not exact matches
The standard test for risk assessment
in relation to life - threatening cardiac rhythm disturbances is currently the left
ventricular ejection fraction, which represents a measure of the heart's
function and measures the volume of the beat
in relation to the overall volume of blood
in the ventricle.
«These findings clearly indicate the need for further study,» said Dr. Lipshultz, while pointing to one of the study's key conclusions: «Subclinical differences
in left
ventricular structure and
function with specific
in - utero antiviral exposures indicate the need for a longitudinal study to assess long - term cardiac risk and cardiac monitoring recommendations.»
The damage of the muscle was followed by a reduction
in heart
function and
ventricular size.
Encapsulation allows for diffusion of pro-angiogenic cytokines and growth factors made by the hMSCs while maintaining them at the site of implantationâ $ ¦ Alginate encapsulated hMSCs attached to the heart with a hydrogel patch resulted
in a highly significant improvement
in left
ventricular function after acute myocardial infarction.
There was an improvement
in left
ventricular ejection fraction and
in myocardial
function.
• Patients must have adequate coagulation (international normalized ratio (INR) or prothrombin time (PT), partial thromboplastin time (PTT) ≤ 1.5 times ULN) • Adequate liver
function (total bilirubin ≤ 1.5 times the ULN, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ≤ 2.5 times ULN Exclusion Criteria: • Presence of active / uncontrolled central nervous system involvement • History of clinically significant cardiac disease; uncontrolled hypertension • Left
ventricular ejection fraction (LVEF) < 45 % • Allogeneic stem cell transplant within 100 days before first dose of study drug • Known history of human immunodeficiency virus (HIV) infection • Chronic or active hepatitis B or C, requiring antiviral therapy • Evidence of history of bleeding disorder, dialysis, or coexisting cancer that is distinct
in primary site or histology from the cancer evaluated
in this study • Serious, uncontrolled infection • Unresolved chronic toxicity > grade 1 from prior therapy • Use of strong CYP3A4 inhibitors or strong inducers within 7 days prior to the start of study treatment and for the duration of the study
Inclusion Criteria: • Availability of tumor tissue for mesothelin expression testing • Histologically - confirmed, mesothelin - expressing metastatic or advanced non-metastatic disease (tumour type specific inclusion criteria) • At least one measurable lesion according to either Response Evaluation Criteria
in Solid Tumors (RECIST) 1.1 or International Thymic Malignancy Interest Group (ITMIG) modified RECIST 1.1 as applicable • Adequate bone marrow, liver, renal and coagulation
function • Left
ventricular ejection fraction (LVEF) ≥ 50 % of the lower limit of normal (LLN) according to local institutional ranges • Eastern Cooperative Oncology Group (ECOG) 0 or 1 Exclusion Criteria: • More than one prior anti - tubulin / microtubule agent • Corneal epitheliopathy or any eye disorder that may predispose the patients to this condition • Symptomatic Central nervous system (CNS) metastases and / or carcinomatous meningitis • Contraindication to both CT and MRI contrast agents • Active hepatitis B or C infection • Pregnant or breast - feeding patients • Tumor type specific exclusion criteria
Symposia VI: Cardiovascular Benefits of Exercise: Insights from Human Studies The session will cover improving exercise tolerance
in heart failure, reversal of impaired cardiac
function in obese adolescents, the effect of exercise on left
ventricular compliance and diastolic
function in the elderly and attenuating premature cardiovascular aging
in Type 2 diabetes through exercise.
Congenital heart defects and left
ventricular non-compaction
in males with loss - of -
function variants
in NONO.
«Short - Term Caloric Restriction Induces Accumulation of Myocardial Triglycerides and Decreases Left
Ventricular Diastolic
Function in Healthy Subjects,» Diabetes, 56, 2849 - 2853.
Researchers found decreased right
ventricular systolic
function in the runners, caused by an increase
in inflammation and a decrease
in blood flow.
Medical research has shown that Vitamin B1 plays very important role
in maintaining healthy heart (especially
ventricular)
function.
Ventricular varicose veins, also known as hypopituitarism, is a term for the decline of the venous drainage
function of the venous system
in the foot region leading to stagnation.
Therefore, the purpose of this clinical trial was to determine the effect of a single standard dose of sotalol on heart
function and rhythm
in dogs diagnosed with
ventricular arrhythmias.
Abstract 12977: Neladenoson, a Partial Adenosine A1 - receptor Agonist, Improves Mitochondrial
Function in Left
Ventricular Cardiomyocytes Isolated From Dogs With Chronic Heart Failure
During his residency, he completed a research project investigating heart
function in Boxer dogs affected with arrhythmogenic right
ventricular cardiomyopathy (ARVC).
Thickening of the walls of the ventricle is associated with a decreased
ventricular chamber volume and abnormal
ventricular relaxation (diastolic
function)
in cats with HCM.
Left
ventricular systolic
function assessment
in patients with dilated heart failure using cardiovascular magnetic resonance